First Trust Advisors »

Aeglea Biotherapeutics shares owned by First Trust Advisors

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by First Trust Advisors from 13F filings

Historical chart of First Trust Advisors investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by First Trust Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by First Trust Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $9.0M 178k 50.44
2024-12-31 $548k 24k 23.28

More positions owned by First Trust Advisors

NVIDIA Corporation (NVDA)
Cisco Systems (CSCO)
Broadcom (AVGO)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
Meta Platforms Cl A (META)
Exxon Mobil Corporation (XOM)
Palo Alto Networks (PANW)
Crowdstrike Hldgs Cl A (CRWD)
Fortinet (FTNT)
Amazon (AMZN)
Lam Research Corp Com New (LRCX)
Chevron Corporation (CVX)
Applied Materials (AMAT)

View all positions for First Trust Advisors

Top funds holding Aeglea Biotherapeutics

FMR
BlackRock
Rtw Investments
Vanguard Group
Fairmount Funds Management
Perceptive Advisors
VR Adviser
Vanguard Capital Management
Driehaus Capital Management
State Street Corporation
Paradigm Biocapital Advisors
Commodore Capital
TCG Crossover Management
Tang Capital Management
Capital Research and Management Company - Division 3

View all funds holding Aeglea Biotherapeutics